Cite
HARVARD Citation
Herbrich, S. et al. (2021). Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML. Journal for immunotherapy of cancer. 9 (7), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Herbrich, S. et al. (2021). Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML. Journal for immunotherapy of cancer. 9 (7), p. . [Online].